Back to top

Myriad Genetics Inc: (NASD: MYGN)

(U.S: NASD) As of Apr 17, 2014 03:59 PM ET

 Add to portfolio

 ZacksTrade Now

$37.97 USD

-0.36 (-0.94%)

Volume: 2,095,794

Zacks Rank : 1-Strong Buy [?] 1        

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.94%
2 Buy 19.04%
3 Hold 10.56%
4 Sell 4.8%
5 Strong Sell 2.59%
S&P 500 10.39%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Income Statements

Fiscal Year end for MYRIAD GENETICS falls in the month of June .

All items in Millions except EPS data.

6/30/13 6/30/12 6/30/11 6/30/10 6/30/09
Sales 613 496 402 363 327
Cost Of Goods 80 65 47 44 43
Gross Profit 534 431 355 318 283
Selling & Adminstrative & Depr. & Amort Expenses 306 251 198 183 157
Income After Depreciation & Amortization 228 180 158 135 126
Non-Operating Income 5 4 2 6 10
Interest Expense 0 0 0 0 0
Pretax Income 233 185 160 141 136
Income Taxes 86 72 59 -11 0
Minority Interest 0 0 0 0 0
Investment Gains/Losses 0 0 0 0 0
Other Income/Charges 0 0 0 0 0
Income From Cont. Operations 147 112 101 152 136
Extras & Discontinued Operations 0 0 0 0 -52
Net Income 147 112 101 152 85
Depreciation Footnote 6/30/13 6/30/12 6/30/11 6/30/10 6/30/09
Income Before Depreciation & Amortization 237 189 165 142 136
Depreciation & Amortization (Cash Flow) 9 9 7 7 9
Income After Depreciation & Amortization 228 180 158 135 126
Earnings Per Share Data 6/30/13 6/30/12 6/30/11 6/30/10 6/30/09
Average Shares 83.33 86.47 91.70 99.15 98.57
Diluted EPS Before Non-Recurring Items 1.77 1.30 1.10 1.39 1.38
Diluted Net EPS 1.77 1.30 1.10 1.54 0.86

Fiscal Year end for MYRIAD GENETICS falls in the month of June .

All items in Millions except EPS data.

3/31/14 12/31/13 9/30/13 6/30/13 3/31/13
Sales NA 204.06 202.47 174.12 156.47
Cost Of Goods NA 26.13 25.48 22.08 20.33
Gross Profit NA 177.92 176.98 152.05 136.13
SG&A, R&D, and Dept/Amort Expenses 0.00 94.93 94.07 86.14 78.21
Income After SG&A, R&D, and Dept/Amort Expenses 0.00 82.99 82.91 65.91 57.92
Non-Operating Income NA 1.14 0.92 1.32 1.32
Interest Expense NA 0.00 0.00 0.00 0.00
Pretax Income NA 84.14 83.82 67.23 59.24
Income Taxes NA 33.78 28.36 23.17 21.34
Minority Interest NA 0.00 0.00 0.00 0.00
Investment Gains/Losses NA 0.00 0.00 0.00 0.00
Other Income/Charges NA 0.00 0.00 0.00 0.00
Income From Cont. Operations NA 50.36 55.47 44.08 37.89
Extras & Discontinued Operations NA 0.00 0.00 0.00 0.00
Net Income NA 50.36 55.47 44.08 37.89
Earnings Per Share Data 3/31/14 12/31/13 9/30/13 6/30/13 3/31/13
Average Shares NA 76.83 81.80 82.64 82.36
Diluted EPS Before Non-Recurring Items NA 0.66 0.68 0.53 0.46
Diluted Net EPS NA 0.66 0.68 0.53 0.46
 

MYGN Chart by YCharts